CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- 4 Open-market buy 10% owner bought 71,315 shares at $5.23 ($372,977)
- 4 Open-market buy 10% owner bought 15,585 shares at an average $5.85 ($91,242)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 14,000 shares at $7.46 ($104,440)
- 4 Open-market sale President and CEO sold 34,294 shares at $7.87 ($269,791)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 20,614 shares at $7.22 ($148,782)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 76,511 shares (grant or award)
- 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 15,698 shares at $3.62 ($56,827)
- 4 Open-market sale President and CEO sold 11,430 shares at $3.61 ($41,262)
- 4 Open-market sale Chief Financial Officer sold 1,584 shares at $3.61 ($5,718)
Page 1 of 9 · 167 filings